Proportion of participants experiencing adverse events · Patients with acute low‐back pain
It is very uncertain whether selective COX‐2 inhibitors changes proportion of participants experiencing adverse events compared with non‐selective NSAIDs (very low certainty).
1 finding from 1 review
Urinary continence within 1 week after catheter removal MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP probably leads to higher urinary continence within 1 week after catheter removal MCID: 5%… compared with standard RALP (moderate certainty).
1 finding from 1 review
Urinary continence 3 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher urinary continence 3 months after surgery MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Serious adverse events · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes serious adverse events compared with standard RALP (very low certainty).
1 finding from 1 review
Urinary continence 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP showed no clear difference in urinary continence 12 months after surgery MCID: 5% absolute… compared with standard RALP (moderate certainty).
1 finding from 1 review
Potency 12 months after surgery MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes potency 12 months after surgery MCID: 5% absolute difference compared with standard RALP (very low certainty).
1 finding from 1 review
Positive surgical margins MCID: 5% absolute difference · men (ages > 18 years) with clinically localized prostate cancer
Retzius‐sparing RALP may leads to higher positive surgical margins MCID: 5% absolute difference compared with standard RALP (low certainty).
1 finding from 1 review
Biochemical recurrence‐free survival · men (ages > 18 years) with clinically localized prostate cancer
It is very uncertain whether retzius‐sparing RALP changes biochemical recurrence‐free survival compared with standard RALP (very low certainty).
1 finding from 1 review
Health status ‐ STI rate · Adolescents and youth age 14 to 24 years
1 finding from 1 review
Health status ‐ Abortion rate · Adolescents and youth age 14 to 24 years
1 finding from 1 review
Health behaviour change ‐ Contraceptive use · Adolescents and youth age 14 to 24 years
1 finding from 1 review
Health Service Utilisation · Adolescents and youth age 14 to 24 years
1 finding from 1 review
Unintended consequences · Adolescents and youth age 14 to 24 years
1 finding from 1 review
SRH knowledge · Adolescents and youth age 14 to 24 years
1 finding from 1 review
Health status and well‐being ‐ STI incidence (chlamydia) · Adolescents and youth age 14 to 24 years
Digital targeted client communication via mobile devices showed no clear difference in health status and well‐being ‐ STI incidence (chlamydia) compared with digital, non‐targeted communication (low certainty).
1 finding from 1 review
Health behaviour change ‐ Condom use · Adolescents and youth age 14 to 24 years
It is very uncertain whether digital targeted client communication via mobile devices changes health behaviour change ‐ Condom use compared with digital, non‐targeted communication (very low certainty).
1 finding from 1 review
Health status ‐ Abortion rate · Adolescents and youth age 14 to 24 years
1 finding from 1 review
Health behaviour change ‐ Contraceptive use at last sex · Adolescents and youth age 14 to 24 years
It is very uncertain whether digital targeted client communication via mobile devices changes health behaviour change ‐ Contraceptive use at last sex compared with digital, non‐targeted communication (very low certainty).
1 finding from 1 review
Health service utilization ‐ Clinic attendance for STI/HIV testing · Adolescents and youth age 14 to 24 years
Digital targeted client communication via mobile devices may leads to higher health service utilization ‐ Clinic attendance for STI/HIV testing… compared with digital, non‐targeted communication (low certainty).
1 finding from 1 review
Health behaviour change ‐ Condom use · Adolescents and youth age 14 to 24 years
It is very uncertain whether digital targeted client communication via mobile devices changes health behaviour change ‐ Condom use compared with standard care or no intervention (very low certainty).
1 finding from 1 review